Table 1 Comparison of clinical data for NSCLC patients in non-DDR, DDR-somatic, and DDR-germline groups
Characteristics | N | Level | non_DDR N (%) | DDR_somatic N (%) | DDR_germline N (%) | P value |
|---|---|---|---|---|---|---|
Total | 5235 | Â | 3096 | 1489 | 650 | Â |
Age | 5232 |  | 62 (16–94) | 64 (23–107) | 62 (27–92) | 1.43E−07 |
Gender | 5235 | Female | 1590 (51.36%) | 554 (37.21%) | 293 (45.08%) | 1.9443E−18 |
Male | 1506 (48.64%) | 935 (62.79%) | 357 (54.92%) | Â | ||
Stage | 2380 | I | 255 (19.26%) | 48 (6.43%) | 48 (15.48%) | 5.2446E−13 |
II | 129 (9.74%) | 59 (7.91%) | 29 (9.35%) | |||
III | 242 (18.28%) | 157 (21.05%) | 64 (20.65%) | |||
IV | 698 (52.72%) | 482 (64.61%) | 169 (54.52%) | |||
Dignosis | 3888 | NSCLC | 2266 (98.65%) | 1075 (96.85%) | 475 (98.75%) | 0.00071134 |
SCLC | 31 (1.35%) | 35 (3.15%) | 6 (1.25%) | |||
Subtype | 3544 | LUAD | 1923 (91.22%) | 827 (82.95%) | 382 (87.02%) | 1.0291E−09 |
LUSC | 148 (7.02%) | 140 (14.04%) | 50 (11.39%) | |||
Others | 37 (1.76%) | 30 (3.01%) | 7 (1.59%) |